SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently drawing intense community focus due to a combination of legal setbacks involving fraud allegations and broader market volatility that has triggered significant selling pressure. Investors are actively debating the company's valuation, questioning the feasibility of its ambitious AI and robotics initiatives, and reacting to widespread concerns over the current economic and geopolitical environment.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is surging as investors pivot to energy plays due to a major supply disruption at Qatar's LNG facilities, fueling a potential short squeeze on its low-float ordinary shares. The community is heavily focused on the company's strategic position in European energy security, with intense discussion surrounding its recent reserve volume increases and the broader geopolitical instability impacting gas prices.

This first memecoin ever created completely by AI.

Turbo Toad Token

Turbo Toad Token ($TURBO) is generating intense community buzz as investors capitalize on its status as a prominent AI-generated meme coin with high trading volume. The community is actively debating its technical setup, closely monitoring resistance levels, and expressing strong conviction in a potential rally toward the penny mark as they anticipate broader market momentum.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant volatility as investors debate the impact of the Kodiak Building Partners acquisition alongside ongoing concerns regarding share dilution and macro headwinds in the construction sector. While some community members remain bullish on Brad Jacobs' long-term consolidation strategy and anticipated acquisition pipeline, others are expressing frustration over the recent downward price pressure and uncertainty surrounding the integration timeline.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is trending as investors digest a fiscal third-quarter earnings report that featured a revenue miss and subsequent stock price decline, leading to an increase in bargain-hunting activity among market participants. The community is actively debating the company's long-term value as a dividend aristocrat versus the immediate impact of its current financial performance and broader sector-wide pressure on medical device stocks.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The Other segment includes DLP products, calculators, and custom application-specific integrated circuits products. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is currently the focus of market debate as investors weigh the company's long-term capital expansion and data center potential against a cautious near-term revenue outlook. Community discussion remains polarized, with long-term investors highlighting consistent dividends and industrial recovery, while active traders express frustration over recent price volatility and stalled growth patterns.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Investors are closely monitoring the Grayscale Ethereum Mini Trust as the broader crypto market shows resilience, with community sentiment shifting toward long-term accumulation despite recent volatility and regulatory headwinds. Discussion remains heavily focused on the interplay between institutional ETF inflows, macroeconomic conditions, and the potential impact of legislative developments on the Ethereum ecosystem.

Forum Energy Technologies, Inc. designs, manufactures, and distributes products to the oil and natural gas industry. It operates through the Drilling and Completions and Artificial Lift and Downhole segments. The Drilling and Completions segment designs, manufactures and supplies products and solutions to the drilling, subsea, coiled tubing, well stimulation and intervention markets, including applications in oil and natural gas, renewable energy, defense and communications. The Artificial Lift and Downhole segment designs, manufactures and supplies products and solutions for the artificial lift, production and infrastructure markets. The company was founded in 2005 and is headquartered in Houston, TX.

Forum Energy Technologies Inc

Forum Energy Technologies is attracting investor attention as its recent Variperm acquisition and deleveraging efforts signal a shift toward stronger free cash flow and potential share repurchases. The community is actively discussing the stock's valuation disconnect and its positioning as a key beneficiary of resilient international activity and rebounding natural gas drilling demand.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is capturing significant community attention as investors debate its potential for a major breakout, with many highlighting its resilience and year-to-date performance relative to other leading cryptocurrencies. The sentiment remains polarized, with bullish traders pointing toward upcoming network upgrades and whale accumulation, while skeptics express frustration over stagnant price action and compare the asset to other market alternatives.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm Holdings is currently a major focus for traders as they weigh strong quarterly growth and expanding merchant partnerships against a volatile macro environment, including concerns over consumer credit stress and rising delinquency rates. The community remains deeply divided, with bulls pointing to the company's clear leadership in the Buy Now, Pay Later space and consistent earnings beats, while bears cite valuation concerns and broader fintech sector headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The financing uses a single-asset SPV, allowing BioAtla to fund a pivotal study without a broader equity raise.</li><li>BioAtla retains majority ownership of Oz-V, keeping 65% control across solid tumor indications after the transaction closes.</li><li>Phase 3 enrollment is expected to begin in early 2026.</li></ul>Shares of BioAtla Inc. (BCAB) slipped nearly 4% in premarket trading on Wednesday after early gains faded, as investors weighed the structure of the company’s $40 million special purpose vehicle (SPV) financing to advance its lead cancer program.<h2 class="st-heading-2">SPV Deal Funds Late-Stage Trial</h2>BioAtla said the SPV transaction with GATC Health Corp. is designed to fund a registrational Phase 3 trial of ozuriftamab vedotin (Oz-V) in patients whose oropharyngeal cancer has progressed after prior treatments.&nbsp;The company will receive an initial $5 million to support general operations and trial expenses, with the remaining $35 million expected to close in the first quarter of 2026 as the study begins.Following completion, BioAtla will retain 65% ownership of Oz-V across all solid tumor indications, while the SPV, backed by Inversagen AI LLC, will hold the remaining 35%.<h2 class="st-heading-2">Investor Focus On Structure</h2>The single-asset SPV approach allows BioAtla to fund a pivotal trial without a broader equity raise, but the structure appeared to draw a cautious response from investors after the initial premarket rally. Under the arrangement, the SPV will share in future development and commercialization economics for Oz-V.<h2 class="st-heading-2">Phase 3 Path&nbsp;</h2>BioAtla will lead execution of the Phase 3 study, with patient enrollment expected to begin in early 2026.&nbsp;The company said the trial is intended to support a potential accelerated approval pathway in the U.S. Oz-V has received Fast Track designation from the FDA for recurrent or metastatic squamous cell carcinoma of the head and neck.<h2 class="st-heading-2">BioAtla Retains Lead Role On Oz-V</h2>The company said the financing provides a near-term path to advance Oz-V while preserving majority ownership, and noted ongoing discussions around expanding the drug’s use into other HPV-positive solid tumors, including cervical cancer.&nbsp;BioAtla and GATC Health also expect to collaborate with Inversagen AI on additional research tied to senescence and longevity technologies, with BioAtla retaining rights for cancer applications.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for BioAtla was ‘bearish’ amid ‘high’ message volume.<figure class="image"><img style="aspect-ratio:973/141;" src="https://news.stocktwits-cdn.com/bcab_ss_png_1ab7393b71.webp" alt="bcab ss.png" width="973" height="141"><figcaption>BCAB sentiment and message volume as of December 31| Source: Stocktwits</figcaption></figure>One user said the market had yet to fully price in the $40 million upfront component of the deal.<stembedurl>https://stocktwits.com/BiotechValues/message/640486061</stembedurl>Another user said the deal fell short of a true global license agreement, pointing instead to the SPV structure and its terms.<stembedurl>https://stocktwits.com/SDBiotechInvestor/message/640485518</stembedurl><a href="https://stocktwits.com/symbol/BCAB">BioAtla’s stock</a> has risen 21% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the BioAtla logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

BioAtla Stock Slips Premarket After Early Pop As Investors Weigh $40M SPV Deal For Phase 3 Cancer Trial

The company disclosed the terms and timeline of an SPV arrangement tied to its Oz-V development program.

Equity

Big short fame Michael Burry-run Scion Asset Management’s September quarter 13F <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/1649339/000090514824003106/xslForm13F_X02/informationtable.xml">report</a> filed late Thursday showed increased exposure to its China stock holdings Alibaba Group Holding Ltd. (<a class="mention" data-mention="$BABA" data-symbol-id="BABA" href="https://stocktwits.com/symbol/BABA" target="_blank">$BABA</a>), Baidu, Inc. (<a class="mention" data-mention="$BIDU" data-symbol-id="BIDU" href="https://stocktwits.com/symbol/BIDU" target="_blank">$BIDU</a>) and JD.com. Inc. (<a class="mention" data-mention="$JD" data-symbol-id="JD" href="https://stocktwits.com/symbol/JD" target="_blank">$JD</a>). The hedge-fund manager, however, covered much of his positions in these stocks with put options.&nbsp;Burry is known for accurately predicting the 2007 subprime mortgage crisis that later morphed into the global financial crisis.At the end of the third quarter, Scion held 200,000 Alibaba ADRs valued at $21.22 million, up from 155,000 ADRs worth $11.16 million at the end of the second quarter.He hedged his Alibaba bet by buying put options on 168,900 ADRs. This strategy insulates him against any potential drop in Alibaba shares.&nbsp;Alibaba shares have rebounded nicely this year amid China’s concerted efforts to stimulate domestic growth. The e-commerce giant is scheduled to report its second-quarter results before the market opens on Friday.Burry’s firm increased its Baidu holding from 75,000 ADRs, valued at $6.49 million, to 125,000 ADRs worth $13.16 million. It also bought put options on 83,000 Baidu ADRs.The firm loaded up ADRs of Alibaba’s peer JD, increasing its stake in the company from 250,000 ADRs to 500,000 ADRs. The value of JD,com holdings swelled from $6.46 million to $20 million. Bury also bought puts on JD.com for 500,000 in underlying shares.On the other hand, Burry halved RealReal, Inc. (<a class="mention" data-mention="$REAL" data-symbol-id="REAL" href="https://stocktwits.com/symbol/REAL" target="_blank">$REAL</a>) holdings from 1 million shares to 500,00 shares. It also significantly cut its stake in&nbsp;American Coastal Insurance Corporation (<a class="mention" data-mention="$ACIC" data-symbol-id="ACIC" href="https://stocktwits.com/symbol/ACIC" target="_blank">$ACIC</a>) from 251,892 to 100,000.Scion fully cashed out of oncology-focused biotech BioAtla, Inc. (<a class="mention" data-mention="$BCAB" data-symbol-id="BCAB" href="https://stocktwits.com/symbol/BCAB" target="_blank">$BCAB</a>) and office real estate investment trust Hudson Pacific Properties, Inc. (<a class="mention" data-mention="$HPP" data-symbol-id="HPP" href="https://stocktwits.com/symbol/HPP" target="_blank">$HPP</a>).On Stocktwits, sentiment towards Burry’s China holdings is muted.&nbsp;Sentiment toward Alibaba was 'neutral' on Stocktwits platform, although improving from a 'bearish' stance a day ago.<figure class="image"><a href="https://stocktwits.com/symbol/BABA"><img style="aspect-ratio:632/133;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/baba_bury_sentiment_76d1568b0e.png" alt="baba-bury-sentiment.png" width="632" height="133"></a><figcaption>BABA sentiment and message volume November 15, 2024 premarket as of 4:06 am ET | Source:&nbsp;Stocktwits</figcaption></figure>&nbsp;JD.com elicited 'bearish sentiment' (36/100) from the retail, although message activity remained 'extremely high,' possibly due to the earnings report released Thursday.<figure class="image"><a href="https://stocktwits.com/symbol/JD"><img style="aspect-ratio:630/135;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/jd_sentiment_cffa43fe76.png" alt="jd-sentiment.png" width="630" height="135"></a><figcaption>JD sentiment and message volume November 15, 2024 premarket as of 4:06 am ET | Source:&nbsp;Stocktwits</figcaption></figure>Baidu did not fare any better, with the retail mood 'bearish' (45/100) on Stocktwits, although message volume, a proxy for activity, was 'high.'<figure class="image"><a href="https://stocktwits.com/symbol/BIDU"><img style="aspect-ratio:632/140;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/bidu_sentiment_fb301f5932.png" alt="bidu-sentiment.png" width="632" height="140"></a><figcaption>BIDU sentiment and message volume November 15, 2024 premarket as of 4:06 am ET | Source:&nbsp;Stocktwits</figcaption></figure>As of 4:06 am ET, Alibaba shares eased 0.63% to $90.01, while JD.com climbed 1.83% to $33.96 and Baidu gained 1.18% to $85.05.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/warren-buffett-s-berkshire-initiates-positions-in-domino-s-pizza-pool-corp-does-retail-share-the-sentiment/cJ4F7DqRfp">Warren Buffett’s Berkshire Initiates Positions In Domino’s Pizza, Pool Corp: Does Retail Share The Sentiment?</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

Chinese stocks are seeing green shoots of recovery amid stimulus measures to reinvigorate growth.

Michael Burry Cautiously Ups Alibaba, JD.com, Baidu Bets With Offsetting Hedges: Retail Doesn’t Share Big Short Investor’s Optimism

Burry is known for accurately predicting the 2007 subprime mortgage crisis that later morphed into the global financial crisis.

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.

BCAB
BioAtla Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BCAB News

BCABBioAtla Inc